APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Female Sexual Dysfunction Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Female Sexual Dysfunction Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173991310322 December 2025182 pages

Choose your research edition.

Industry ResearchFemale Sexual Dysfunction Treatment Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Female Sexual Dysfunction Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Female Sexual Dysfunction Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Female Sexual Dysfunction Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Female Sexual Dysfunction Treatment Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Female Sexual Dysfunction Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Female Sexual Dysfunction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Female Sexual Dysfunction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Female Sexual Dysfunction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Female Sexual Dysfunction Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Female Sexual Dysfunction Treatment include Novo Nordisk AS, Sprout Pharmaceuticals Inc., Emotional Brain BV, Duchesnay Inc. and AMAG Pharmaceuticals Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Female Sexual Dysfunction Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Female Sexual Dysfunction Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Female Sexual Dysfunction Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Female Sexual Dysfunction Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Female Sexual Dysfunction Treatment Segment by Company

Novo Nordisk AS

Sprout Pharmaceuticals Inc.

Emotional Brain BV

Duchesnay Inc.

AMAG Pharmaceuticals Inc.

Female Sexual Dysfunction Treatment Segment by Type

Non-hormonal Therapy

Hormonal Therapy

Female Sexual Dysfunction Treatment Segment by Application

Pelvic Floor Dysfunction

Post-orgasmic Diseases

Orgasm Disorders

Sexual Arousal Disorders

Sexual Pain Disorders

Sexual Desire Disorders

Other

Female Sexual Dysfunction Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Sexual Dysfunction Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Female Sexual Dysfunction Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Sexual Dysfunction Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Female Sexual Dysfunction Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Female Sexual Dysfunction Treatment industry.

Chapter 3: Detailed analysis of Female Sexual Dysfunction Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Sexual Dysfunction Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Non-hormonal Therapy Table 3. Key Players of Hormonal Therapy Table 4. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pelvic Floor Dysfunction Table 6. Key Players of Post-orgasmic Diseases Table 7. Key Players of Orgasm Disorders Table 8. Key Players of Sexual Arousal Disorders Table 9. Key Players of Sexual Pain Disorders Table 10. Key Players of Sexual Desire Disorders Table 11. Key Players of Other Table 12. Global Female Sexual Dysfunction Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Female Sexual Dysfunction Treatment Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Female Sexual Dysfunction Treatment Market Share by Region (2021-2026) Table 15. Global Female Sexual Dysfunction Treatment Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Female Sexual Dysfunction Treatment Market Share by Region (2027-2032) Table 17. Female Sexual Dysfunction Treatment Industry Trends Table 18. Female Sexual Dysfunction Treatment Industry Drivers Table 19. Female Sexual Dysfunction Treatment Industry Opportunities and Challenges Table 20. Female Sexual Dysfunction Treatment Industry Restraints Table 21. Global Female Sexual Dysfunction Treatment Revenue by Company (US$ Million) & (2021-2026) Table 22. Global Female Sexual Dysfunction Treatment Revenue Market Share by Company (2021-2026) Table 23. Global Female Sexual Dysfunction Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global Female Sexual Dysfunction Treatment Key Company Head Office and Area Served Table 25. Global Female Sexual Dysfunction Treatment Company, Product Type & Application Table 26. Global Female Sexual Dysfunction Treatment Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global Female Sexual Dysfunction Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global Female Sexual Dysfunction Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Female Sexual Dysfunction Treatment Market Size by Type (2021-2026) & (US$ Million) Table 31. Global Female Sexual Dysfunction Treatment Market Size by Type (2027-2032) & (US$ Million) Table 32. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2021-2026) Table 33. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2027-2032) Table 34. Global Female Sexual Dysfunction Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Female Sexual Dysfunction Treatment Market Size by Application (2021-2026) & (US$ Million) Table 36. Global Female Sexual Dysfunction Treatment Market Size by Application (2027-2032) & (US$ Million) Table 37. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2021-2026) Table 38. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2027-2032) Table 39. Novo Nordisk AS Company Information Table 40. Novo Nordisk AS Business Overview Table 41. Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Novo Nordisk AS Female Sexual Dysfunction Treatment Product Portfolio Table 43. Novo Nordisk AS Recent Development Table 44. Sprout Pharmaceuticals Inc. Company Information Table 45. Sprout Pharmaceuticals Inc. Business Overview Table 46. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio Table 48. Sprout Pharmaceuticals Inc. Recent Development Table 49. Emotional Brain BV Company Information Table 50. Emotional Brain BV Business Overview Table 51. Emotional Brain BV Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Emotional Brain BV Female Sexual Dysfunction Treatment Product Portfolio Table 53. Emotional Brain BV Recent Development Table 54. Duchesnay Inc. Company Information Table 55. Duchesnay Inc. Business Overview Table 56. Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Duchesnay Inc. Female Sexual Dysfunction Treatment Product Portfolio Table 58. Duchesnay Inc. Recent Development Table 59. AMAG Pharmaceuticals Inc. Company Information Table 60. AMAG Pharmaceuticals Inc. Business Overview Table 61. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio Table 63. AMAG Pharmaceuticals Inc. Recent Development Table 64. North America Female Sexual Dysfunction Treatment Market Size by Type (2021-2026) & (US$ Million) Table 65. North America Female Sexual Dysfunction Treatment Market Size by Type (2027-2032) & (US$ Million) Table 66. North America Female Sexual Dysfunction Treatment Market Size by Application (2021-2026) & (US$ Million) Table 67. North America Female Sexual Dysfunction Treatment Market Size by Application (2027-2032) & (US$ Million) Table 68. North America Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. North America Female Sexual Dysfunction Treatment Market Size by Country (2021-2026) Table 70. North America Female Sexual Dysfunction Treatment Market Size by Country (2027-2032) Table 71. Europe Female Sexual Dysfunction Treatment Market Size by Type (2021-2026) & (US$ Million) Table 72. Europe Female Sexual Dysfunction Treatment Market Size by Type (2027-2032) & (US$ Million) Table 73. Europe Female Sexual Dysfunction Treatment Market Size by Application (2021-2026) & (US$ Million) Table 74. Europe Female Sexual Dysfunction Treatment Market Size by Application (2027-2032) & (US$ Million) Table 75. Europe Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. Europe Female Sexual Dysfunction Treatment Market Size by Country (2021-2026) Table 77. Europe Female Sexual Dysfunction Treatment Market Size by Country (2027-2032) Table 78. China Female Sexual Dysfunction Treatment Market Size by Type (2021-2026) & (US$ Million) Table 79. China Female Sexual Dysfunction Treatment Market Size by Type (2027-2032) & (US$ Million) Table 80. China Female Sexual Dysfunction Treatment Market Size by Application (2021-2026) & (US$ Million) Table 81. China Female Sexual Dysfunction Treatment Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia Female Sexual Dysfunction Treatment Market Size by Type (2021-2026) & (US$ Million) Table 83. Asia Female Sexual Dysfunction Treatment Market Size by Type (2027-2032) & (US$ Million) Table 84. Asia Female Sexual Dysfunction Treatment Market Size by Application (2021-2026) & (US$ Million) Table 85. Asia Female Sexual Dysfunction Treatment Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Asia Female Sexual Dysfunction Treatment Market Size by Country (2021-2026) Table 88. Asia Female Sexual Dysfunction Treatment Market Size by Country (2027-2032) Table 89. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2021-2026) & (US$ Million) Table 90. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2027-2032) & (US$ Million) Table 91. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2021-2026) & (US$ Million) Table 92. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2027-2032) & (US$ Million) Table 93. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2021-2026) Table 95. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2027-2032) Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Female Sexual Dysfunction Treatment Product Image Figure 2. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Female Sexual Dysfunction Treatment Market Share by Type: 2025 VS 2032 Figure 4. Non-hormonal Therapy Image Figure 5. Hormonal Therapy Image Figure 6. Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Female Sexual Dysfunction Treatment Market Share by Application: 2025 VS 2032 Figure 8. Pelvic Floor Dysfunction Image Figure 9. Post-orgasmic Diseases Image Figure 10. Orgasm Disorders Image Figure 11. Sexual Arousal Disorders Image Figure 12. Sexual Pain Disorders Image Figure 13. Sexual Desire Disorders Image Figure 14. Other Image Figure 15. Global Female Sexual Dysfunction Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 17. Global Female Sexual Dysfunction Treatment Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Female Sexual Dysfunction Treatment Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Female Sexual Dysfunction Treatment Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Female Sexual Dysfunction Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Female Sexual Dysfunction Treatment Revenue Market Share by Type (2021-2032) Figure 24. Global Female Sexual Dysfunction Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Female Sexual Dysfunction Treatment Revenue Market Share by Application (2021-2032) Figure 26. North America Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 27. North America Female Sexual Dysfunction Treatment Market Share by Type (2021-2032) Figure 28. North America Female Sexual Dysfunction Treatment Market Share by Application (2021-2032) Figure 29. North America Female Sexual Dysfunction Treatment Market Share by Country (2021-2032) Figure 30. United States Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Canada Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 34. Europe Female Sexual Dysfunction Treatment Market Share by Type (2021-2032) Figure 35. Europe Female Sexual Dysfunction Treatment Market Share by Application (2021-2032) Figure 36. Europe Female Sexual Dysfunction Treatment Market Share by Country (2021-2032) Figure 37. Germany Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 38. France Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Italy Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Russia Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 44. China Female Sexual Dysfunction Treatment Market Share by Type (2021-2032) Figure 45. China Female Sexual Dysfunction Treatment Market Share by Application (2021-2032) Figure 46. Asia Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 47. Asia Female Sexual Dysfunction Treatment Market Share by Type (2021-2032) Figure 48. Asia Female Sexual Dysfunction Treatment Market Share by Application (2021-2032) Figure 49. Asia Female Sexual Dysfunction Treatment Market Share by Country (2021-2032) Figure 50. Japan Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 54. India Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 55. Australia Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Country (2021-2032) Figure 60. Brazil Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 65. UAE Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Chile Female Sexual Dysfunction Treatment Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Non-hormonal Therapy
  • Hormonal Therapy
Applications
  • Pelvic Floor Dysfunction
  • Post-orgasmic Diseases
  • Orgasm Disorders
  • Sexual Arousal Disorders
  • Sexual Pain Disorders
  • Sexual Desire Disorders
  • Other
Companies covered
  • Novo Nordisk AS
  • Sprout Pharmaceuticals Inc.
  • Emotional Brain BV
  • Duchesnay Inc.
  • AMAG Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Non-hormonal Therapy
  5. 1.2.3 Hormonal Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Female Sexual Dysfunction Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Pelvic Floor Dysfunction
  9. 1.3.3 Post-orgasmic Diseases
  10. 1.3.4 Orgasm Disorders
  11. 1.3.5 Sexual Arousal Disorders
  12. 1.3.6 Sexual Pain Disorders
  13. 1.3.7 Sexual Desire Disorders
  14. 1.3.8 Other
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Female Sexual Dysfunction Treatment Growth Trends by Region
  17. 1.5.1 Global Female Sexual Dysfunction Treatment Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Female Sexual Dysfunction Treatment Market Size by Region (2021-2026)
  19. 1.5.3 Female Sexual Dysfunction Treatment Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Female Sexual Dysfunction Treatment Market Dynamics
  1. 2.1 Female Sexual Dysfunction Treatment Industry Trends
  2. 2.2 Female Sexual Dysfunction Treatment Industry Drivers
  3. 2.3 Female Sexual Dysfunction Treatment Industry Opportunities and Challenges
  4. 2.4 Female Sexual Dysfunction Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Female Sexual Dysfunction Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Female Sexual Dysfunction Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Female Sexual Dysfunction Treatment Key Company Head office and Area Served
  4. 3.4 Global Female Sexual Dysfunction Treatment Company, Product Type & Application
  5. 3.5 Global Female Sexual Dysfunction Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Female Sexual Dysfunction Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Female Sexual Dysfunction Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Female Sexual Dysfunction Treatment Tier 1, Tier 2, and Tier 3
4 Female Sexual Dysfunction Treatment Market by Type
  1. 4.1 Global Female Sexual Dysfunction Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Female Sexual Dysfunction Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Female Sexual Dysfunction Treatment Market Size Share by Type (2021-2032)
5 Female Sexual Dysfunction Treatment Market by Application
  1. 5.1 Global Female Sexual Dysfunction Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Female Sexual Dysfunction Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Female Sexual Dysfunction Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novo Nordisk AS
  2. 6.1.1 Novo Nordisk AS Company Information
  3. 6.1.2 Novo Nordisk AS Business Overview
  4. 6.1.3 Novo Nordisk AS Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novo Nordisk AS Female Sexual Dysfunction Treatment Product Portfolio
  6. 6.1.5 Novo Nordisk AS Recent Developments
  7. 6.2 Sprout Pharmaceuticals Inc.
  8. 6.2.1 Sprout Pharmaceuticals Inc. Company Information
  9. 6.2.2 Sprout Pharmaceuticals Inc. Business Overview
  10. 6.2.3 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sprout Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio
  12. 6.2.5 Sprout Pharmaceuticals Inc. Recent Developments
  13. 6.3 Emotional Brain BV
  14. 6.3.1 Emotional Brain BV Company Information
  15. 6.3.2 Emotional Brain BV Business Overview
  16. 6.3.3 Emotional Brain BV Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Emotional Brain BV Female Sexual Dysfunction Treatment Product Portfolio
  18. 6.3.5 Emotional Brain BV Recent Developments
  19. 6.4 Duchesnay Inc.
  20. 6.4.1 Duchesnay Inc. Company Information
  21. 6.4.2 Duchesnay Inc. Business Overview
  22. 6.4.3 Duchesnay Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Duchesnay Inc. Female Sexual Dysfunction Treatment Product Portfolio
  24. 6.4.5 Duchesnay Inc. Recent Developments
  25. 6.5 AMAG Pharmaceuticals Inc.
  26. 6.5.1 AMAG Pharmaceuticals Inc. Company Information
  27. 6.5.2 AMAG Pharmaceuticals Inc. Business Overview
  28. 6.5.3 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AMAG Pharmaceuticals Inc. Female Sexual Dysfunction Treatment Product Portfolio
  30. 6.5.5 AMAG Pharmaceuticals Inc. Recent Developments
7 North America
  1. 7.1 North America Female Sexual Dysfunction Treatment Market Size (2021-2032)
  2. 7.2 North America Female Sexual Dysfunction Treatment Market Size by Type
  3. 7.2.1 North America Female Sexual Dysfunction Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Female Sexual Dysfunction Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Female Sexual Dysfunction Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Female Sexual Dysfunction Treatment Market Size by Application
  7. 7.3.1 North America Female Sexual Dysfunction Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Female Sexual Dysfunction Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Female Sexual Dysfunction Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Female Sexual Dysfunction Treatment Market Size by Country
  11. 7.4.1 North America Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Female Sexual Dysfunction Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Female Sexual Dysfunction Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Female Sexual Dysfunction Treatment Market Size (2021-2032)
  2. 8.2 Europe Female Sexual Dysfunction Treatment Market Size by Type
  3. 8.2.1 Europe Female Sexual Dysfunction Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Female Sexual Dysfunction Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Female Sexual Dysfunction Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Female Sexual Dysfunction Treatment Market Size by Application
  7. 8.3.1 Europe Female Sexual Dysfunction Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Female Sexual Dysfunction Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Female Sexual Dysfunction Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Female Sexual Dysfunction Treatment Market Size by Country
  11. 8.4.1 Europe Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Female Sexual Dysfunction Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Female Sexual Dysfunction Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Female Sexual Dysfunction Treatment Market Size (2021-2032)
  2. 9.2 China Female Sexual Dysfunction Treatment Market Size by Type
  3. 9.2.1 China Female Sexual Dysfunction Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Female Sexual Dysfunction Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Female Sexual Dysfunction Treatment Market Share by Type (2021-2032)
  6. 9.3 China Female Sexual Dysfunction Treatment Market Size by Application
  7. 9.3.1 China Female Sexual Dysfunction Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Female Sexual Dysfunction Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Female Sexual Dysfunction Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Female Sexual Dysfunction Treatment Market Size (2021-2032)
  2. 10.2 Asia Female Sexual Dysfunction Treatment Market Size by Type
  3. 10.2.1 Asia Female Sexual Dysfunction Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Female Sexual Dysfunction Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Female Sexual Dysfunction Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Female Sexual Dysfunction Treatment Market Size by Application
  7. 10.3.1 Asia Female Sexual Dysfunction Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Female Sexual Dysfunction Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Female Sexual Dysfunction Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Female Sexual Dysfunction Treatment Market Size by Country
  11. 10.4.1 Asia Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Female Sexual Dysfunction Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Female Sexual Dysfunction Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Female Sexual Dysfunction Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst